Drug Shortage Report for ASMANEX TWISTHALER

Last updated on 2021-02-24 History
Report ID 106456
Drug Identification Number 02243596
Brand name ASMANEX TWISTHALER
Common or Proper name mometasone furoate dry powder inhaler
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) MOMETASONE FUROATE
Strength(s) 400MCG
Dosage form(s) POWDER
Route of administration INHALATION
Packaging size 60dose
ATC code R03BA
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2020-05-29
Actual start date 2020-05-25
Estimated end date 2021-06-18
Actual end date
Shortage status Actual shortage
Updated date 2021-02-24
Company comments Back orders were partially released on Jul 23th 2020, Sep 11th 2020, Oct 28th 2020 and Feb 15th 2021.
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v21 2021-02-24 English Compare
v20 2021-02-15 French Compare
v19 2021-02-15 English Compare
v18 2020-12-03 English Compare
v17 2020-11-23 English Compare
v16 2020-10-13 English Compare
v15 2020-10-07 English Compare
v14 2020-09-02 English Compare
v13 2020-09-02 English Compare
v12 2020-08-26 English Compare
v11 2020-07-09 English Compare
v10 2020-07-09 English Compare
v9 2020-07-06 English Compare
v8 2020-06-22 English Compare
v7 2020-05-29 English Compare
v6 2020-05-04 English Compare
v5 2020-04-29 English Compare
v4 2020-04-28 English Compare
v3 2020-04-08 English Compare
v2 2020-02-18 French Compare

Showing 1 to 20 of 21